SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024936
Filing Date
2021-05-06
Accepted
2021-05-06 16:02:36
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vor-10q_20210331.htm 10-Q 2148585
2 EX-31.1 vor-ex311_9.htm EX-31.1 19187
3 EX-31.2 vor-ex312_8.htm EX-31.2 19191
4 EX-32.1 vor-ex321_6.htm EX-32.1 17159
  Complete submission text file 0001564590-21-024936.txt   5510072

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vor-20210331.xml EX-101.INS 911618
6 XBRL TAXONOMY EXTENSION SCHEMA vor-20210331.xsd EX-101.SCH 35061
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vor-20210331_cal.xml EX-101.CAL 32317
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vor-20210331_def.xml EX-101.DEF 106769
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20210331_lab.xml EX-101.LAB 281613
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20210331_pre.xml EX-101.PRE 219758
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 21897608
SIC: 2836 Biological Products, (No Diagnostic Substances)